poly-refractory rheumatoid arthritis | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

22,221 results for “poly-refractory rheumatoid arthritis”

Cellares to Lay Off 100 Employees After Losing Large Cell Therapy Manufacturing Partner

Artiva's AlloNK Receives FDA Fast Track Designation for Refractory Rheumatoid Arthritis

Novel CAR-T Regulatory Cell Therapy Shows Promise in Refractory Rheumatoid Arthritis

Artiva Biotherapeutics Receives FDA Fast Track Designation for AlloNK Cell Therapy in Refractory Rheumatoid Arthritis

Sonoma Biotherapeutics Reports Promising Phase 1 Results for CAR-Treg Therapy in Refractory Rheumatoid Arthritis

Vagus Nerve Stimulation Shows Promise for Rheumatoid Arthritis Treatment

Rise Therapeutics Initiates Phase 1 Trial of R-2487 for Rheumatoid Arthritis

Early Control of Rheumatoid Arthritis Improves Hemostatic Imbalance

Seven-Year Study Reveals Hidden Pre-Clinical Stage of Rheumatoid Arthritis

Higher BMI Reduces Effectiveness of JAK Inhibitors in Rheumatoid Arthritis

Page 1 of 326